CoChat
Sign Up
Cited by 110

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Toward a mechanistic understanding of poly-and perfluoroalkylated substances and cancer

Boyd, Raya I., Ahmad, Saeed, Singh, Ratnakar, Fazal, Zeeshan, Prins, Gail S., Madak Erdogan, Zeynep, Irudayaraj, Joseph, Spinella, Michael J.·2022·Cancers
DOI 10.3390/cancers14122919PMC PMC9220899
Open this paper in CoChat — free account

Abstract

Poly- and perfluoroalkylated substances (PFAS) are chemicals that persist and bioaccumulate in the environment and are found in nearly all human populations through several routes of exposure. Human occupational and community exposure to PFAS has been associated with several cancers, including cancers of the kidney, testis, prostate, and liver. While evidence suggests that PFAS are not directly mutagenic, many diverse mechanisms of carcinogenicity have been proposed. In this mini-review, we organize these mechanisms into three major proposed pathways of PFAS action—metabolism, endocrine disruption, and epigenetic perturbation—and discuss how these distinct but interdependent pathways may explain many of the proposed pro-carcinogenic effects of the PFAS class of environmental contaminants. Notably, each of the pathways is predicted to be highly sensitive to the dose and window of exposure which may, in part, explain the variable epidemiologic and experimental evidence linking PFAS and cancer. We highlight testicular and prostate cancer as models to validate this concept.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers14122919

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Chemical structures of Poly- and perfluoroalkylated substances. Structures are based on 2D structures from PubChem accessed 5 June 2022 and assembled in Chem-space.com accessed 5 June 2022.
Figure 1 Chemical structures of Poly- and perfluoroalkylated substances. Structures are based on 2D structures from PubChem accessed 5 June 2022 and assembled in Chem-space.com accessed 5 June 2022.CC BY · PubMed Central
Figure 2 Proposed mechanisms of potential PFAS cancer promotion. PPAR-dependent and -independent reprogramming of metabolism, epigenetics, and endocrine disruption are represented as interconnecting, mutually reinforcing pathways of potential PFAS tumor promotion. The precise details of how PFAS influences these pathways are still uncertain, as is the impact of other proposed PFAS mechanisms, including immunosuppression and oxidative stress.
Figure 2 Proposed mechanisms of potential PFAS cancer promotion. PPAR-dependent and -independent reprogramming of metabolism, epigenetics, and endocrine disruption are represented as interconnecting, mutually reinforcing pathways of potential PFAS tumor promotion. The precise details of how PFAS influences these pathways are still uncertain, as is the impact of other proposed PFAS mechanisms, including immunosuppression and oxidative stress.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 145

  1. Chohan, 2021, Per and polyfluoroalkyl substances scientific literature review: Water exposure, impact on human health, and implications for regulatory reform, Rev. Environ. Health, 36, 235, 10.1515/reveh-2020-0049 · DOI
  2. Xu, 2021, PFAS and their substitutes in groundwater: Occurrence, transformation and remediation, J. Hazard. Mater., 412, 125159, 10.1016/j.jhazmat.2021.125159 · DOI
  3. Laitinen, 2014, Firefighters’ exposure to perfluoroalkyl acids and 2-butoxyethanol present in firefighting foams, Toxicol. Lett., 231, 227, 10.1016/j.toxlet.2014.09.007 · DOI
  4. Calafat, 2007, Polyfluoroalkyl chemicals in the U.S. population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000, Environ. Health Perspect., 115, 1596, 10.1289/ehp.10598 · DOI · Paper page
  5. Fu, 2016, Occurrence, temporal trends, and half-lives of perfluoroalkyl acids (PFAAs) in occupational workers in China, Sci. Rep., 6, 38039, 10.1038/srep38039 · DOI
  6. Emmett, 2006, Community exposure to perfluorooctanoate: Relationships between serum concentrations and exposure sources, J. Occup. Environ. Med., 48, 759, 10.1097/01.jom.0000232486.07658.74 · DOI
  7. Ingelido, 2018, Biomonitoring of perfluorinated compounds in adults exposed to contaminated drinking water in the Veneto Region, Italy, Environ. Int., 110, 149, 10.1016/j.envint.2017.10.026 · DOI
  8. Fenton, 2021, Per- and polyfluoroalkyl substance toxicity and human health review: Current state of knowledge and strategies for informing future research, Environ. Toxicol. Chem., 40, 606, 10.1002/etc.4890 · DOI · Paper page
  9. Sunderland, 2019, A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects, J. Expo. Sci. Environ. Epidemiol., 29, 131, 10.1038/s41370-018-0094-1 · DOI · Paper page
  10. Steenland, 2020, Review: Evolution of evidence on PFOA and health following the assessments of the C8 Science Panel, Environ. Int., 145, 106125, 10.1016/j.envint.2020.106125 · DOI
  11. Steenland, 2021, PFAS and cancer, a scoping review of the epidemiologic evidence, Environ. Res., 194, 110690, 10.1016/j.envres.2020.110690 · DOI
  12. Kim, M.J., Moon, S., Oh, B.C., Jung, D., Ji, K., Choi, K., and Park, Y.J. (2018). Association between perfluoroalkyl substances exposure and thyroid function in adults: A meta-analysis. PLoS ONE, 13. · DOI
  13. Rodgers, 2018, Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms, Environ. Res., 160, 152, 10.1016/j.envres.2017.08.045 · DOI
  14. Gilliland, 1993, Mortality among employees of a perfluorooctanoic acid production plant, J. Occup. Med., 35, 950, 10.1097/00043764-199309000-00020 · DOI
  15. Barry, 2013, Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant, Environ. Health Perspect., 121, 1313, 10.1289/ehp.1306615 · DOI
  16. Vieira, 2013, Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: A geographic analysis, Environ. Health Perspect., 121, 318, 10.1289/ehp.1205829 · DOI
  17. Long, 2011, Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: A case control study, Environ. Health, 10, 88, 10.1186/1476-069X-10-88 · DOI
  18. Long, 2014, Breast cancer risk after exposure to perfluorinated compounds in Danish women: A case-control study nested in the Danish National Birth Cohort, Cancer Causes Control., 25, 1439, 10.1007/s10552-014-0446-7 · DOI
  19. Raleigh, 2014, Mortality and cancer incidence in ammonium perfluorooctanoate production workers, Occup. Environ. Med., 71, 500, 10.1136/oemed-2014-102109 · DOI
  20. Farias, 2017, Carcinogenic risk of emerging persistent organic pollutant perfluorooctane sulfonate (PFOS): A proposal of classification, Regul. Toxicol. Pharmacol., 83, 66, 10.1016/j.yrtph.2016.11.021 · DOI
  21. Bartell, 2021, Critical review on PFOA, kidney cancer, and testicular cancer, J. Air Waste Manag. Assoc., 71, 663, 10.1080/10962247.2021.1909668 · DOI · Paper page
  22. Lau, 2007, Perfluoroalkyl acids: A review of monitoring and toxicological findings, Toxicol. Sci., 99, 366, 10.1093/toxsci/kfm128 · DOI · Paper page
  23. Butenhoff, 2012, Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague-Dawley rats, Toxicology, 298, 1, 10.1016/j.tox.2012.04.001 · DOI
  24. Biegel, 2001, Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats, Toxicol. Sci., 60, 44, 10.1093/toxsci/60.1.44 · DOI
  25. Temkin, A.M., Hocevar, B.A., Andrews, D.Q., Naidenko, O.V., and Kamendulis, L.M. (2020). Application of the key characteristics of carcinogens to per and polyfluoroalkyl substances. Int. J. Environ. Res. Public Health, 17. · DOI
  26. Crebelli, 2019, Can sustained exposure to PFAS trigger a genotoxic response? A comprehensive genotoxicity assessment in mice after subacute oral administration of PFOA and PFBA, Regul. Toxicol. Pharmacol., 106, 169, 10.1016/j.yrtph.2019.05.005 · DOI
  27. Emerce, 2018, Genotoxicity assessment of perfluoroalkyl substances on human sperm, Toxicol. Ind. Health, 34, 884, 10.1177/0748233718799191 · DOI
  28. Long, 2015, Perfluoroalkylated substances (PFAS) affect oxidative stress biomarkers in vitro, Chemosphere, 129, 239, 10.1016/j.chemosphere.2014.10.014 · DOI
  29. Panaretakis, 2001, Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, Toxicol. Appl. Pharmacol., 173, 56, 10.1006/taap.2001.9159 · DOI
  30. Klaunig, 2012, Mode of action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and human relevance, Reprod. Toxicol., 33, 410, 10.1016/j.reprotox.2011.10.014 · DOI
  31. Kim, 2021, Epigenetic changes by per- and polyfluoroalkyl substances (PFAS), Environ. Pollut., 279, 116929, 10.1016/j.envpol.2021.116929 · DOI
  32. Hanahan, 2011, Hallmarks of cancer: The next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  33. Thompson, 2006, Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: A comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha, Toxicol. Sci., 92, 476, 10.1093/toxsci/kfl014 · DOI
  34. Wolf, 2008, Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths, Toxicol. Sci., 106, 162, 10.1093/toxsci/kfn166 · DOI
  35. Dixit, 2022, The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics, Exp. Mol. Pathol., 124, 104723, 10.1016/j.yexmp.2021.104723 · DOI
  36. Li, 2019, Maternal exposure to perfluorooctanoic acid (PFOA) causes liver toxicity through PPAR-α pathway and lowered histone acetylation in female offspring mice, Environ. Sci. Pollut. Res. Int., 26, 18866, 10.1007/s11356-019-05258-z · DOI
  37. Das, 2017, Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis, Toxicology, 378, 37, 10.1016/j.tox.2016.12.007 · DOI
  38. Chappell, 2020, Assessment of the mode of action underlying the effects of GenX in mouse liver and implications for assessing human health risks, Toxicol. Pathol., 48, 494, 10.1177/0192623320905803 · DOI
  39. Schlezinger, 2021, Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPARα mice fed an American diet, Toxicol. Appl. Pharmacol., 426, 115644, 10.1016/j.taap.2021.115644 · DOI
  40. Fragki, 2021, Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: What do we know and what not?, Crit. Rev. Toxicol., 51, 141, 10.1080/10408444.2021.1888073 · DOI
  41. Frisbee, 2009, The C8 health project: Design, methods, and participants, Environ. Health Perspect., 117, 1873, 10.1289/ehp.0800379 · DOI
  42. Eriksen, K.T., Raaschou-Nielsen, O., McLaughlin, J.K., Lipworth, L., Tjønneland, A., Overvad, K., and Sørensen, M. (2013). Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population. PLoS ONE, 8. · DOI
  43. Liu, 2018, Association among total serum isomers of perfluorinated chemicals, glucose homeostasis, lipid profiles, serum protein and metabolic syndrome in adults: NHANES, 2013-2014, Environ. Pollut., 232, 73, 10.1016/j.envpol.2017.09.019 · DOI
  44. Hu, 2003, Alterations in cell membrane properties caused by perfluorinated compounds, Comp. Biochem. Physiol. C Toxicol. Pharmacol., 135, 77, 10.1016/S1532-0456(03)00043-7 · DOI
  45. Fitzgerald, 2018, Partitioning and accumulation of perfluoroalkyl substances in model lipid bilayers and bacteria, Environ. Sci. Technol., 52, 10433, 10.1021/acs.est.8b02912 · DOI
  46. Wolf, 2008, Comparative hepatic effects of perfluorooctanoic acid and WY 14,643 in PPAR-alpha knockout and wild-type mice, Toxicol. Pathol., 36, 632, 10.1177/0192623308318216 · DOI
  47. Milhas, 2020, Metabolic remodeling induced by adipocytes: A new achilles’ heel in invasive breast cancer?, Curr. Med. Chem., 27, 3984, 10.2174/0929867325666180426165001 · DOI
  48. Xu, H., Chen, Y., Gu, M., Liu, C., Chen, Q., Zhan, M., and Wang, Z. (2021). Fatty acid metabolism reprogramming in advanced prostate cancer. Metabolites, 11. · DOI
  49. Liu, 2021, The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis, Pharmacol. Res., 165, 105420, 10.1016/j.phrs.2021.105420 · DOI
  50. Yu, 2016, Effects of perfluorooctanoic acid on metabolic profiles in brain and liver of mouse revealed by a high-throughput targeted metabolomics approach, Sci. Rep., 6, 23963, 10.1038/srep23963 · DOI
  51. Tan, 2012, Global liver proteome analysis using iTRAQ labeling quantitative proteomic technology to reveal biomarkers in mice exposed to perfluorooctane sulfonate (PFOS), Environ. Sci. Technol., 46, 12170, 10.1021/es3027715 · DOI
  52. Domazet, 2016, Longitudinal associations of exposure to perfluoroalkylated substances in childhood and adolescence and indicators of adiposity and glucose metabolism 6 and 12 years later: The European Youth Heart Study, Diabetes Care, 39, 1745, 10.2337/dc16-0269 · DOI
  53. Alderete, 2019, Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis, Environ. Int., 126, 445, 10.1016/j.envint.2019.02.047 · DOI
  54. Stratakis, 2020, Prenatal exposure to perfluoroalkyl substances associated with increased susceptibility to liver injury in children, Hepatology, 72, 1758, 10.1002/hep.31483 · DOI
  55. Wang, 2017, Serum metabolome biomarkers associate low-level environmental perfluorinated compound exposure with oxidative /nitrosative stress in humans, Environ. Pollut., 229, 168, 10.1016/j.envpol.2017.04.086 · DOI
  56. Lv, 2013, Glucose and lipid homeostasis in adult rat is impaired by early-life exposure to perfluorooctane sulfonate, Environ. Toxicol., 28, 532, 10.1002/tox.20747 · DOI
  57. Quist, 2015, Hepatic mitochondrial alteration in CD-1 mice associated with prenatal exposures to low doses of perfluorooctanoic acid (PFOA), Toxicol. Pathol., 43, 546, 10.1177/0192623314551841 · DOI
  58. Varsi, 2021, Quantitation of linear and branched perfluoroalkane sulfonic acids (PFSAs) in women and infants during pregnancy and lactation, Environ. Int., 160, 107065, 10.1016/j.envint.2021.107065 · DOI
  59. Kempisty, 2021, Overview of the mechanisms of action of selected bisphenols and perfluoroalkyl chemicals on the male reproductive axes, Front. Genet., 12, 692897, 10.3389/fgene.2021.692897 · DOI
  60. Green, 2021, Endocrine disrupting chemicals: Impacts on human fertility and fecundity during the peri-conception period, Environ. Res., 194, 110694, 10.1016/j.envres.2020.110694 · DOI
  61. Tarapore, P., and Ouyang, B. (2021). Perfluoroalkyl Chemicals and Male Reproductive Health: Do PFOA and PFOS Increase Risk for Male Infertility?. Int. J. Environ. Res. Public Health, 18. · DOI
  62. Wan, 2011, Testicular signaling is the potential target of perfluorooctanesulfonate-mediated subfertility in male mice, Biol. Reprod., 84, 1016, 10.1095/biolreprod.110.089219 · DOI
  63. Feng, 2015, Chronic exposure of female mice to an environmental level of perfluorooctane sulfonate suppresses estrogen synthesis through reduced histone H3K14 acetylation of the star promoter leading to deficits in follicular development and ovulation, Toxicol. Sci., 148, 368, 10.1093/toxsci/kfv197 · DOI
  64. Zhao, B., Li, L., Liu, J., Li, H., Zhang, C., Han, P., Zhang, Y., Yuan, X., Ge, R.S., and Chu, Y. (2014). Exposure to perfluorooctane sulfonate in utero reduces testosterone production in rat fetal Leydig cells. PLoS ONE, 9. · DOI
  65. Jensen, 2008, Emerging endocrine disrupters: Perfluoroalkylated substances, Int. J. Androl., 31, 161, 10.1111/j.1365-2605.2008.00870.x · DOI
  66. Zhang, 2014, Proteomic analysis of mouse testis reveals perfluorooctanoic acid-induced reproductive dysfunction via direct disturbance of testicular steroidogenic machinery, J. Proteome Res., 13, 3370, 10.1021/pr500228d · DOI
  67. Salgado, 2014, Perfluorooctane sulfonate effects on the reproductive axis in adult male rats, Environ. Res., 134, 158, 10.1016/j.envres.2014.07.006 · DOI
  68. Sabovic, 2019, Endocrine disruption of androgenic activity by perfluoroalkyl substances: Clinical and experimental evidence, J. Clin. Endocrinol. Metab, 104, 1259, 10.1210/jc.2018-01855 · DOI
  69. Itoh, 2016, Association of perfluoroalkyl substances exposure in utero with reproductive hormone levels in cord blood in the Hokkaido Study on Environment and Children’s Health, Environ. Int., 94, 51, 10.1016/j.envint.2016.05.011 · DOI
  70. Song, 2018, Effects of perfluorooctanoic acid exposure during pregnancy on the reproduction and development of male offspring mice, Andrologia, 50, e13059, 10.1111/and.13059 · DOI
  71. White, 2011, Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice, Environ. Health Perspect., 119, 1070, 10.1289/ehp.1002741 · DOI
  72. White, 2007, Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring, Toxicol. Sci., 96, 133, 10.1093/toxsci/kfl177 · DOI
  73. Zhang, 2021, Perfluorooctanoic acid exposure in early pregnancy induces oxidative stress in mice uterus and liver, Environ. Sci. Pollut. Res. Int., 28, 66355, 10.1007/s11356-021-15453-6 · DOI
  74. Mallozzi, M., Leone, C., Manurita, F., Bellati, F., and Caserta, D. (2017). Endocrine disrupting chemicals and endometrial cancer: An overview of recent laboratory evidence and epidemiological studies. Int. J. Environ. Res. Public Health, 14. · DOI
  75. Vested, 2013, Associations of in utero exposure to perfluorinated alkyl acids with human semen quality and reproductive hormones in adult men, Environ. Health Perspect., 121, 453, 10.1289/ehp.1205118 · DOI
  76. Mondal, 2016, perfluoroalkyl substances, sex hormones, and insulin-like growth factor-1 at 6-9 years of age: A cross-sectional analysis within the C8 Health Project, Environ. Health Perspect., 124, 1269, 10.1289/ehp.1509869 · DOI
  77. Tsai, 2015, Association between perfluoroalkyl substances and reproductive hormones in adolescents and young adults, Int. J. Hyg. Environ. Health, 218, 437, 10.1016/j.ijheh.2015.03.008 · DOI
  78. Toporova, 2020, Nuclear receptors are the major targets of endocrine disrupting chemicals, Mol. Cell Endocrinol., 502, 110665, 10.1016/j.mce.2019.110665 · DOI
  79. Margolis, 2021, Associations between Exposures to Perfluoroalkyl Substances and Diabetes, Hyperglycemia, or Insulin Resistance: A Scoping Review, J. Xenobiot., 11, 115, 10.3390/jox11030008 · DOI · Paper page
  80. Walker, 2016, Minireview: Epigenomic plasticity and vulnerability to EDC exposures, Mol. Endocrinol., 30, 848, 10.1210/me.2016-1086 · DOI
  81. Murk, 2017, Association between DNA methylation profiles in leukocytes and serum levels of persistent organic pollutants in Dutch men, Environ. Epigenet., 3, dvx001
  82. Watkins, 2014, Associations between serum perfluoroalkyl acids and LINE-1 DNA methylation, Environ. Int., 63, 71, 10.1016/j.envint.2013.10.018 · DOI
  83. Goldman, 2010, Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds, Epigenetics, 5, 539, 10.4161/epi.5.6.12378 · DOI
  84. Kingsley, 2017, Maternal serum PFOA concentration and DNA methylation in cord blood: A pilot study, Environ. Res., 158, 174, 10.1016/j.envres.2017.06.013 · DOI
  85. Leung, 2018, Identification of sex-specific DNA methylation changes driven by specific chemicals in cord blood in a Faroese birth cohort, Epigenetics, 13, 290, 10.1080/15592294.2018.1445901 · DOI
  86. Miura, 2018, An epigenome-wide study of cord blood DNA methylations in relation to prenatal perfluoroalkyl substance exposure: The Hokkaido study, Environ. Int., 115, 21, 10.1016/j.envint.2018.03.004 · DOI
  87. Kobayashi, 2017, Effects of prenatal perfluoroalkyl acid exposure on cord blood IGF2/H19 methylation and ponderal index: The Hokkaido Study, J. Expo. Sci. Environ. Epidemiol., 27, 251, 10.1038/jes.2016.50 · DOI
  88. Liu, C.Y., Chen, P.C., Lien, P.C., and Liao, Y.P. (2018). Prenatal perfluorooctyl sulfonate exposure and Alu DNA hypomethylation in cord blood. Int. J. Environ. Res Public Health, 15. · DOI
  89. Guo, X.X., He, Q.Z., Li, W., Long, D.X., Pan, X.Y., Chen, C., and Zeng, H.C. (2017). Brain-derived neurotrophic factor mediated perfluorooctane sulfonate induced-neurotoxicity via epigenetics regulation in SK-N-SH cells. Int. J. Mol. Sci., 18. · DOI
  90. Sonkar, 2019, PFOS modulates interactive epigenetic regulation in first-trimester human trophoblast cell line HTR-8/SV(neo), Chem. Res. Toxicol., 32, 2016, 10.1021/acs.chemrestox.9b00198 · DOI
  91. Tian, 2012, Perfluorooctanoic acid induces gene promoter hypermethylation of glutathione-S-transferase Pi in human liver L02 cells, Toxicology, 296, 48, 10.1016/j.tox.2012.03.003 · DOI
  92. Murk, 2017, Persistent organic pollutants alter DNA methylation during human adipocyte differentiation, Toxicol. Vitr., 40, 79, 10.1016/j.tiv.2016.12.011 · DOI
  93. Ma, 2018, Low-level perfluorooctanoic acid enhances 3 T3-L1 preadipocyte differentiation via altering peroxisome proliferator activated receptor gamma expression and its promoter DNA methylation, J. Appl. Toxicol., 38, 398, 10.1002/jat.3549 · DOI
  94. Rashid, 2020, Acute PFOA exposure promotes epigenomic alterations in mouse kidney tissues, Toxicol. Rep., 7, 125, 10.1016/j.toxrep.2019.12.010 · DOI
  95. Wen, 2020, Effect of PFOA on DNA methylation and alternative splicing in mouse liver, Toxicol. Lett., 329, 38, 10.1016/j.toxlet.2020.04.012 · DOI
  96. Wen, 2020, Epigenetic toxicity of PFOA and GenX in HepG2 cells and their role in lipid metabolism, Toxicol. Vitr., 65, 104797, 10.1016/j.tiv.2020.104797 · DOI
  97. Liu, 2020, Perfluorooctanoic acid (PFOA) exposure inhibits DNA methyltransferase activities and alters constitutive heterochromatin organization, Food Chem. Toxicol., 141, 111358, 10.1016/j.fct.2020.111358 · DOI
  98. Ahmad, 2021, PFOA induces alteration in DNA methylation regulators and SARS-CoV-2 targets Ace2 and Tmprss2 in mouse lung tissues, Toxicol. Rep., 8, 1892, 10.1016/j.toxrep.2021.11.014 · DOI
  99. Wan, 2010, Alterations in tumor biomarker GSTP gene methylation patterns induced by prenatal exposure to PFOS, Toxicology, 274, 57, 10.1016/j.tox.2010.05.006 · DOI
  100. Tian, 2019, SAM targeting methylation by the methyl donor, a novel therapeutic strategy for antagonize PFOS transgenerational fertility toxicity, Ecotoxicol. Environ. Saf, 184, 109579, 10.1016/j.ecoenv.2019.109579 · DOI
  101. Rashid, F., Ahmad, S., and Irudayaraj, J.M.K. (2020). Effect of Perfluorooctanoic acid on the epigenetic and tight junction genes of the mouse intestine. Toxics, 8. · DOI
  102. Jabeen, M., Fayyaz, M., and Irudayaraj, J. (2020). Epigenetic modifications, and alterations in cell cycle and apoptosis pathway in A549 lung carcinoma cell line upon exposure to perfluoroalkyl substances. Toxics, 8. · DOI
  103. Dong, 2016, Hepatic miRNA profiles and thyroid hormone homeostasis in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS), Environ. Toxicol. Pharmacol., 41, 201, 10.1016/j.etap.2015.12.009 · DOI
  104. Wang, 2012, Association of perfluorooctanoic acid with HDL cholesterol and circulating miR-26b and miR-199-3p in workers of a fluorochemical plant and nearby residents, Environ. Sci. Technol., 46, 9274, 10.1021/es300906q · DOI
  105. Imir, O.B., Kaminsky, A.Z., Zuo, Q.Y., Liu, Y.J., Singh, R., Spinella, M.J., Irudayaraj, J., Hu, W.Y., Prins, G.S., and Madak Erdogan, Z. (2021). Per- and polyfluoroalkyl substance exposure combined with high-fat diet supports prostate cancer progression. Nutrients, 13. · DOI
  106. Chandra, 2015, Effects of deranged metabolism on epigenetic changes in cancer, Arch. Pharm. Res., 38, 321, 10.1007/s12272-015-0561-3 · DOI
  107. Boukouris, 2016, metabolic enzymes moonlighting in the nucleus: Metabolic regulation of gene transcription, Trends Biochem. Sci., 41, 712, 10.1016/j.tibs.2016.05.013 · DOI
  108. Fleisch, 2012, Environmental epigenetics: A role in endocrine disease?, J. Mol. Endocrinol., 49, R61, 10.1530/JME-12-0066 · DOI
  109. Feroe, 2017, Endocrine disrupting chemicals, transgenerational epigenetics and metabolic diseases, EC Endocrinol. Metab. Res., 21, 31
  110. Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 68, 394, 10.3322/caac.21492 · DOI · Paper page
  111. Lobo, J., Gillis, A.J.M., Jerónimo, C., Henrique, R., and Looijenga, L.H.J. (2019). Human germ cell tumors are developmental cancers: Impact of epigenetics on pathobiology and clinic. Int. J. Mol. Sci. · DOI
  112. Shen, 2018, Integrated molecular characterization of testicular germ cell tumors, Cell Rep., 23, 3392, 10.1016/j.celrep.2018.05.039 · DOI
  113. Litchfield, 2015, Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours, Nat. Commun., 6, 5973, 10.1038/ncomms6973 · DOI
  114. Lim, 2021, Endocrine disrupting chemicals and risk of testicular cancer: A systematic review and meta-analysis, J. Clin. Endocrinol. Metab., 106, e4834
  115. Sharma, 2020, Endocrine-disrupting chemicals and male reproductive health, Reprod. Med. Biol., 19, 243, 10.1002/rmb2.12326 · DOI
  116. Singh, R., Fazal, Z., Freemantle, S.J., and Spinella, M.J. (2021). Between a rock and a hard place: An epigenetic-centric view of testicular germ cell tumors. Cancers, 13. · DOI
  117. Skakkebaek, 2016, Male reproductive disorders and fertility trends: Influences of environment and genetic susceptibility, Physiol. Rev., 96, 55, 10.1152/physrev.00017.2015 · DOI
  118. Selvi, 2020, Effects of testicular dysgenesis syndrome components on testicular germ cell tumor prognosis and oncological outcomes, Int. Braz. J. Urol., 46, 725, 10.1590/s1677-5538.ibju.2019.0387 · DOI
  119. Trabert, 2013, Congenital malformations and testicular germ cell tumors, Int. J. Cancer, 133, 1900, 10.1002/ijc.28207 · DOI
  120. Hanson, 2016, Subfertility increases risk of testicular cancer: Evidence from population-based semen samples, Fertil. Steril., 105, 322, 10.1016/j.fertnstert.2015.10.027 · DOI
  121. Singh, R., Fazal, Z., Corbet, A.K., Bikorimana, E., Rodriguez, J.C., Khan, E.M., Shahid, K., Freemantle, S.J., and Spinella, M.J. (2019). Epigenetic Remodeling through Downregulation of Polycomb Repressive Complex 2 Mediates Chemotherapy Resistance in Testicular Germ Cell Tumors. Cancers, 11. · DOI
  122. Fazal, 2021, Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours, Epigenetics, 16, 1071, 10.1080/15592294.2020.1834926 · DOI
  123. Soteriades, 2019, Cancer Incidence and Mortality in Firefighters: A State-of-the-Art Review and Meta-َAnalysis, Asian Pac. J. Cancer Prev., 20, 3221, 10.31557/APJCP.2019.20.11.3221 · DOI
  124. Petersen, 2020, Per- and polyfluoroalkyl substances and male reproductive health: A systematic review of the epidemiological evidence, J. Toxicol. Environ. Health B Crit. Rev., 23, 276, 10.1080/10937404.2020.1798315 · DOI
  125. Steves, 2018, Per- and polyfluoroalkyl substances impact human spermatogenesis in a stem-cell-derived model, Syst. Biol. Reprod. Med., 64, 225, 10.1080/19396368.2018.1481465 · DOI
  126. Iwabuchi, 2017, Tissue toxicokinetics of perfluoro compounds with single and chronic low doses in male rats, J. Toxicol. Sci., 42, 301, 10.2131/jts.42.301 · DOI
  127. Biegel, 1995, Effects of ammonium perfluorooctanoate on Leydig cell function: In vitro, in vivo, and ex vivo studies, Toxicol. Appl. Pharmacol., 134, 18, 10.1006/taap.1995.1164 · DOI
  128. Zhang, 2020, Effects of gestational perfluorooctane sulfonate exposure on the developments of fetal and adult Leydig cells in F1 males, Environ. Pollut., 262, 114241, 10.1016/j.envpol.2020.114241 · DOI
  129. Lai, 2017, Effects of in utero PFOS exposure on transcriptome, lipidome, and function of mouse testis, Environ. Sci. Technol., 51, 8782, 10.1021/acs.est.7b02102 · DOI
  130. Li, 2018, Perfluorooctane sulfonate impairs rat Leydig cell development during puberty, Chemosphere, 190, 43, 10.1016/j.chemosphere.2017.09.116 · DOI
  131. Tian, 2019, Biphasic effects of perfluorooctanoic acid on steroidogenesis in mouse Leydig tumour cells, Reprod. Toxicol., 83, 54, 10.1016/j.reprotox.2018.11.006 · DOI
  132. York, 2010, Male reproductive system parameters in a two-generation reproduction study of ammonium perfluorooctanoate in rats and human relevance, Toxicology, 271, 64, 10.1016/j.tox.2010.03.005 · DOI
  133. Butenhoff, 2004, The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat, Toxicology, 196, 95, 10.1016/j.tox.2003.11.005 · DOI · Paper page
  134. Liu, 1996, Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats, Fundam Appl. Toxicol., 30, 220, 10.1006/faat.1996.0059 · DOI
  135. Gore, 2015, EDC-2: The Endocrine Society’s second scientific statement on endocrine-disrupting chemicals, Endocr. Rev., 36, E1, 10.1210/er.2015-1010 · DOI · Paper page
  136. Narita, S., Nara, T., Sato, H., Koizumi, A., Huang, M., Inoue, T., and Habuchi, T. (2019). Research evidence on high-fat diet-induced prostate cancer development and progression. J. Clin. Med., 8. · DOI
  137. Freedland, 2004, Examining the relationship between obesity and prostate cancer, Rev. Urol., 6, 73
  138. Vidal, 2020, Obesity, race, and long-term prostate cancer outcomes, Cancer, 126, 3733, 10.1002/cncr.32906 · DOI
  139. Priolo, 2014, AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer, Cancer Res., 74, 7198, 10.1158/0008-5472.CAN-14-1490 · DOI
  140. Hu, 2021, Per- and polyfluoroalkyl substances target and alter human prostate stem-progenitor cells, Biochem. Pharmacol., 197, 114902, 10.1016/j.bcp.2021.114902 · DOI
  141. Band, 2019, Free fatty acids rewire cancer metabolism in obesity-associated breast cancer via estrogen receptor and mTOR signaling, Cancer Res., 79, 2494, 10.1158/0008-5472.CAN-18-2849 · DOI
  142. Singh, 2021, The interplay between prostate cancer genomics, metabolism, and the epigenome: Perspectives and future prospects, Front. Oncol., 11, 704353, 10.3389/fonc.2021.704353 · DOI
  143. Deblois, 2020, Epigenetic switch–induced viral mimicry evasion in chemotherapy-resistant breast cancer, Cancer Discov., 10, 1312, 10.1158/2159-8290.CD-19-1493 · DOI
  144. McDonald, 2017, Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis, Nat. Genet., 49, 367, 10.1038/ng.3753 · DOI · Paper page
  145. Sutendra, 2014, A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation, Cell, 158, 84, 10.1016/j.cell.2014.04.046 · DOI

Cited by

Sorted by citations

See all 110

Metadata

Authors
Boyd, R. I., Ahmad, S., Singh, R., Fazal, Z., Prins, G. S., Madak Erdogan, Z., Irudayaraj, J., & Spinella, M. J.
Affiliations
  • Department of Comparative Biosciences, University of Illinois, Urbana-Champaign, Urbana, IL 61802, USA
  • Department of Bioengineering, University of Illinois, Urbana-Champaign, Urbana, IL 61801, USA
  • Departments of Urology, Pathology and Physiology, College of Medicine, Chicago Center for Health and Environment, University of Illinois Chicago, Chicago, IL 60612, USA
  • Department of Food Science and Human Nutrition, Division of Nutritional Sciences, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA
ORCID
Venue
Cancers
Publisher
MDPI AG
Published
2022-06-14
Volume
14
Issue
12
Pages
2919
ISSN
2072-6694
DOI
10.3390/cancers14122919
PMC
PMC9220899
Cited by
110
References
20
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
  • NCI (R01CA211875, W81XWH2110903)
  • a DOD PRCRP Impact Award (R01CA211875, W81XWH2110903)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review